Other Industry News

BGI's $250 Million Shenzhen IPO Scheduled for July

BGI, a Shenzhen genomics company, is edging closer to an IPO. The company now expects to raise $250 million on Shenzhen's Chi-Next Exchange sometime in July, following all-but-final approvals from Ch... Full Story


  Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces the filing of a new provisional patent application and stock and option awards. L... Full Story

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM

, a biopharmaceutical company focused on the development of new cancer therapies, today announced it has received Institutional Review Board (IRB) approval to conduct its pivotal Phase 3 Study in Temozolomid... Full Story

Chi-Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhibitor HMPL 453 in China

Chi-Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhibitor HMPL 453 in China Hutchison China MediTech Limited (“Chi‑Med”) (AIM/Nasdaq: HCM) has just initiated a Phase I/II clinical ... Full Story

San Francisco's Sinovas Starts $75 Million China VC Fund

Sanovas, a Bay-Area medical device maker, will start a venture capital fund in Suzhou's BioBaypark, which will invest "upwards" of $75 million in Suzhou technologies. Sanovas makes innovati... Full Story

IBM grows Baheal deal to bring Watson genomics to China

IBM and Baheal Pharmaceutical have moved quickly to expand their relationship. Weeks after IBM gave Baheal a starring role in selling its Watson for Oncology product in China, Big Blue has penned a simil... Full Story

Shanghai ChemPartner Plans Reverse Merger with China's Quantum

ShangPharma will merge its Shanghai ChemPartner division, which includes all of the company's CRO/CMO operations, into Quantum Hi-Tech China Biological. The transaction, a reverse merger, allows Chem... Full Story

Resverlogix Closes $10 Million of Equity Subscriptions

today closed its previously-announced offering, issuing a total of $10 million of its equity units. Eastern Capital Limited ("Eastern") and Shenzhen Hepalink Pharmaceutical Co., Ltd. (... Full Story

Zecotek Receives Notice of Allowance in China for New Advanced Formulation of its Worldwide Patented LFS Scintillation Crystal

, a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned division, Zecotek Imaging Systems Pte. Ltd., has rece... Full Story

GSK Forms Respiratory Disease Big Data Project with Guangzhou Institute

GlaxoSmithKline will form a big data partnership with Guangzhou Institute of Respiratory Diseases (GIRD) to develop a respiratory disease management system that will target both asthma and chronic obstru... Full Story

Company Search

Upcoming Events More